Takimoto Chris H

Takimoto Chris H is listed in filings as Director at ALX Oncology Holdings Inc.. This profile follows SEC Form 4 activity through Jan 21, 2026, including sale activity. Recent filings connect the profile to ALX Oncology Holdings Inc. (ALXO) and IGM Biosciences, Inc. (IGMS). The current snapshot covers public activity from Jun 18, 2024 to Jan 21, 2026. Reported amounts are shown as $53.3K to $17.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.